< Back to topics
> Cover Page, Authors, Institutions
> View tables/images/videos
The purpose of this study is to
characterize the oncologic results and toxicity profile of patients treated
with a D90 of ≥180 Gy.
There has been significant
interest in dose escalation using external beam radiation for prostate cancer.
In contrast, the safety and efficacy of doses above the ABS recommended D90 of
145 Gy using brachytherapy has not been established.